Patents by Inventor Min-Kyu Joo

Min-Kyu Joo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10310817
    Abstract: An apparatus and method for modular multiplication. The modular multiplication apparatus includes a first operation unit for performing a first operation based on a structure of at least one of a serial multiplier and a serial squarer-based multiplier; a second operation unit for performing a second operation based on a structure of at least one of the serial multiplier and the serial squarer-based multiplier; an adder unit for outputting the sum of results of the first operation and the second operation, inputting an intermediate value stream to the first input unit, which calculates the product of the intermediate value stream and a zeta parameter, and outputting a High-Order Term as a result of Montgomery Modular Multiplication, wherein the first and second operation units output a result in digit-serial format in order from the least significant digit to the most significant digit.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: June 4, 2019
    Assignee: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventors: Yun-Koo Lee, Dong-Geon Lee, Min-Kyu Joo, Yoen-Cheol Lee, Sang-Woon Yang
  • Patent number: 10286004
    Abstract: Targeting-enhanced anticancer nanoparticles and preparation methods for the nanoparticles are provided. In particular, this invention provides targeting-enhanced anticancer nanoparticles comprising non-covalently bound anticancer drugs, serum albumins as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties. The targeting-enhanced anticancer nanoparticles described in the present invention are characterized by non-covalently bound constituents: anticancer drugs, serum albumin as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties, thus preventing common toxic side effects, enhancing the structural stability of nanoparticles, and enhancing tumor targeting by treatment with electromagnetic waves due to the activity of porphyrin, without structural and functional changes.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: May 14, 2019
    Assignee: JINIS CO., LTD.
    Inventors: Hyeon Jin Kim, Seong Tshool Hong, Hea Jong Chung, Min Kyu Joo, Hea Guk Cho, Jinny Hong
  • Publication number: 20180181374
    Abstract: An apparatus and method for modular multiplication. The modular multiplication apparatus includes a first operation unit for performing a first operation based on a structure of at least one of a serial multiplier and a serial squarer-based multiplier; a second operation unit for performing a second operation based on a structure of at least one of the serial multiplier and the serial squarer-based multiplier; an adder unit for outputting the sum of results of the first operation and the second operation, inputting an intermediate value stream to the first input unit, which calculates the product of the intermediate value stream and a zeta parameter, and outputting a High-Order Term as a result of Montgomery Modular Multiplication, wherein the first and second operation units output a result in digit-serial format in order from the least significant digit to the most significant digit.
    Type: Application
    Filed: November 9, 2017
    Publication date: June 28, 2018
    Inventors: Yun-Koo LEE, Dong-Geon LEE, Min-Kyu JOO, Yoen-Cheol LEE, Sang-Woon YANG
  • Publication number: 20170239369
    Abstract: Targeting-enhanced anticancer nanoparticles and preparation methods for the nanoparticles are provided. In particular, this invention provides targeting-enhanced anticancer nanoparticles comprising non-covalently bound anticancer drugs, serum albumins as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties. The targeting-enhanced anticancer nanoparticles described in the present invention are characterized by non-covalently bound constituents: anticancer drugs, serum albumin as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties, thus preventing common toxic side effects, enhancing the structural stability of nanoparticles, and enhancing tumor targeting by treatment with electromagnetic waves due to the activity of porphyrin, without structural and functional changes.
    Type: Application
    Filed: April 7, 2017
    Publication date: August 24, 2017
    Applicant: JINIS CO., LTD.
    Inventors: Hyeon Jin KIM, Seong Tshool HONG, Hea Jong CHUNG, Min Kyu JOO, Hea Guk CHO, Jinny HONG
  • Patent number: 9662401
    Abstract: This invention encompasses targeting-enhanced anticancer nanoparticles and preparation methods for the same. In particular, this invention provides targeting-enhanced anticancer nanoparticles comprising non-covalently bound anticancer drugs, serum albumins as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties. The targeting-enhanced anticancer nanoparticles described in the present invention are characterized by non-covalently bound constituents: anticancer drugs, serum albumin as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties, thus preventing common toxic side effects, enhancing the structural stability of nanoparticles, and enhancing tumor targeting by treatment with electromagnetic waves due to the activity of porphyrin, without structural and functional changes.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: May 30, 2017
    Assignee: JINIS CO., LTD.
    Inventors: Hyeon Jin Kim, Seong Tshool Hong, Hea Jong Chung, Min Kyu Joo, Hea Guk Cho, Jinny Hong
  • Publication number: 20150290332
    Abstract: This invention encompasses targeting-enhanced anticancer nanoparticles and preparation methods for the same. In particular, this invention provides targeting-enhanced anticancer nanoparticles comprising non-covalently bound anticancer drugs, serum albumins as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties. The targeting-enhanced anticancer nanoparticles described in the present invention are characterized by non-covalently bound constituents: anticancer drugs, serum albumin as the nanoparticle base material, and porphyrin compounds as tumor-targeting moieties, thus preventing common toxic side effects, enhancing the structural stability of nanoparticles, and enhancing tumor targeting by treatment with electromagnetic waves due to the activity of porphyrin, without structural and functional changes.
    Type: Application
    Filed: May 15, 2013
    Publication date: October 15, 2015
    Applicant: JINIS CO., LTD.
    Inventors: Hyeon Jin Kim, Seong Tshool Hong, Hea Jong Chung, Min Kyu Joo, Hea Guk Cho, Jinny Hong
  • Patent number: 7885258
    Abstract: Disclosed is a packet switch equipment and a band control method using same. In accordance with one embodiment of the invention, a number of packets are sampled by using a packet sampling function provided by a packet switch chip, and the sampled packets are transmitted to a CPU. By using the transmitted sample packets, the total amount of bandwidth used by a corresponding user is estimated based on the source MAC address or the source IP address. If the estimated value exceeds a predetermined threshold, a bandwidth limitation function is applied to the user that is providing packets that exceed the bandwidth. A number of users can be dynamically recognized even when they are undefined, and a dynamic bandwidth limitation function is performed by tracking the bandwidth used by a corresponding user.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: February 8, 2011
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Min-Kyu Joo, Hoon-Jae Kim, Han-Seung Park, Seong-Ha Kim
  • Patent number: 7864782
    Abstract: In a packet processing apparatus and method in an ethernet switching system, an introduced packet is discarded by switching to a dummy port instead of trapping the packet until a layer 3 table of an ethernet switch chip is updated, thereby operating an Address Resolution Protocol (ARP) after having minimized a central processing unit (CPU) load. The packet processing apparatus, upon receipt of a first packet headed for a destination Internet protocol (IP) address not existing in the packet processing unit from a source host, transmits an ARP request packet to the destination IP address so as to acquire routing information of a destination host.
    Type: Grant
    Filed: September 19, 2006
    Date of Patent: January 4, 2011
    Assignee: Samsung Electronics Co., Ltd.
    Inventor: Min-Kyu Joo
  • Publication number: 20080170567
    Abstract: Disclosed is a packet switch apparatus applied to Internet Protocol (IP) network, the packet switch apparatus including: an Ethernet switch to perform packet switching, the Ethernet switch including a plurality of ports and a layer 3 table. The plurality of ports include a dummy port, which has an available port number allowing hardware-access, discards packets switched to the dummy port, and exists as a logical number, the layer 3 table storing Media Access Control (MAC) addresses corresponding to IP addresses of hosts and information about corresponding connection ports. A controller determines the nonexistence of the MAC address, virtually sets the MAC address corresponding to the destination IPv6 address, and updates the layer 3 table of the Ethernet switch chip as if the host of the set virtual MAC address were connected to the dummy port, when the MAC address corresponding to destination IPv6 address of the packet trapped by the Ethernet switch chip does not exist.
    Type: Application
    Filed: January 15, 2008
    Publication date: July 17, 2008
    Inventor: Min-Kyu JOO
  • Publication number: 20080002685
    Abstract: Disclosed is a packet switch equipment and a band control method using same. In accordance with one embodiment of the invention, a number of packets are sampled by using a packet sampling function provided by a packet switch chip, and the sampled packets are transmitted to a CPU. By using the transmitted sample packets, the total amount of bandwidth used by a corresponding user is estimated based on the source MAC address or the source IP address. If the estimated value exceeds a predetermined threshold, a bandwidth limitation function is applied to the user that is providing packets that exceed the bandwidth. A number of users can be dynamically recognized even when they are undefined, and a dynamic bandwidth limitation function is performed by tracking the bandwidth used by a corresponding user.
    Type: Application
    Filed: December 12, 2006
    Publication date: January 3, 2008
    Inventors: Min-Kyu Joo, Hoon-Jae Kim, Han-Seung Park, Seong-Ha Kim
  • Publication number: 20070165648
    Abstract: In a packet processing apparatus and method in an ethernet switching system, an introduced packet is discarded by switching to a dummy port instead of trapping the packet until a layer 3 table of an ethernet switch chip is updated, thereby operating an Address Resolution Protocol (ARP) after having minimized a central processing unit (CPU) load. The packet processing apparatus, upon receipt of a first packet headed for a destination Internet protocol (IP) address not existing in the packet processing unit from a source host, transmits an ARP request packet to the destination IP address so as to acquire routing information of a destination host.
    Type: Application
    Filed: September 19, 2006
    Publication date: July 19, 2007
    Inventor: Min-Kyu Joo